Skip to main content
José Luis Molinuevo

José Luis Molinuevo

Scientific Director

Alzheimer's Prevention Program

Group leader of the Clinical, Biomarker and Risk factors Research Group 

Scientific activity:

  • Principal Investigation of Alfa Study, Alfa+, Alfa Genetics, Alfa Cognition and Barcelonaβeta Dementia Prevention Research Clinic. 
  • National lead of EPAD, a European consortium for the prevention of Alzheimer's dementia. 
  • Co-lead of TRIBEKA, an international consortium to generate an open access neuroimaging platform.
  • Principal Investigator at BBRC of several clinical trials (Generation I, Generation II and AB1601). 
  • Membership in research networks, associations and international working groups: 
    • Member of the Neuroscience Steering Committee of the Biomarkers Consortium of the Foundation for the National Institutes of Health.
    • Member of the CSF Appropriate Use Criteria Workgroup.
    • Member of the National Institute on Aging and Alzheimer's Association (NIA-AA) Diagnostic Criteria.
    • Member of the European Alzheimer Disease Consortium.
    • Member of the Dementia Panel for the European Association of Neurology.
    • Member of the Alzheimer Biomarker Standarization Initiative.
    • Member of the  CIBER de Fragilidad y Envejecimiento Saludable.
  • He has provided scientific advice or has been an investigator or data monitoring board member for for Novartis, Pfizer, Eisai, Janssen-Cilag, Lundbeck, Roche, Bayer, Bristol-Myers Squibb, GE Health Care, Merz, MSD, GlaxoSmithKline, Astra-Zeneca, Avid, Lilly, Boehringer-Inghelmein, Biokit, Piramal, IBL y Fujireibio-Europe.
  • Scientific, technical and/or assessment commitees: 
    • Member of the Alzheimer’s Disease International (ADI) Executive Committee for the Medical and Scientific Panel (MSAP)
    • Scientist Panel on Dementia and cognitive disorders in EFNS (European Federation of Neurological Societies)
    • Expert reviewer for the Spanish National Agency for Evaluation and Prospective (ANEP)
    • Editor Journal of Alzheimer's disease
    • Editor Neurology Journal
    • Editorial Board Member of Alzheimer’s Research & Therapy
    • Editorial Board Member of Alzheimer's & Dementia: Translational Research & Clinical Interventions


  • 2010: Alzheimer's research award by the Spanish Society of Neurology. 
  • 2003: International Junior Investigator Award by the International College of Geriatric Psychoneuropharmacology.
  • 1998: Emili Letang Award (best residence and scientific research project), Hospital Clínic i Universitari de Barcelona.


  • 2001: PhD in Neurology. University of Barcelona, Spain. 
  • 1998: Residence in Neurology. University of Barcelona, Spain.
  • 1994: MD in Medicine. University of Valencia, Spain. 

Other positions

  • 2001-2016: Responsible of the Alzheimer's and Other Cognitive Units at Hospital Clínic de Barcelona and researcher at IDIBAPS. 
  • 1998-2001: Consultant Neurologist of the Movement Disease Unit at Hospital Clínic de Barcelona.
  • 1994-1998: Neurology resident at Hospital Clínic de Barcelona.